Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30353 | 170 | 29.0 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
432 | 3 | CRYPTOSPORIDIUM//BACTERIAL VAGINOSIS//ENTAMOEBA HISTOLYTICA | 27277 |
475 | 2 | CRYPTOSPORIDIUM//ENTAMOEBA HISTOLYTICA//MICROSPORIDIA | 15845 |
30353 | 1 | NITAZOXANIDE//TIZOXANIDE//HEPATOL GASTROENTEROL INFECT DIS | 170 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NITAZOXANIDE | authKW | 5705923 | 38% | 49% | 65 |
2 | TIZOXANIDE | authKW | 1811172 | 6% | 92% | 11 |
3 | HEPATOL GASTROENTEROL INFECT DIS | address | 431082 | 4% | 40% | 6 |
4 | THIAZOLIDES | authKW | 374204 | 3% | 42% | 5 |
5 | CONFIRMATORY STAGE | authKW | 359241 | 1% | 100% | 2 |
6 | CRYPTONAZ POWDER | authKW | 359241 | 1% | 100% | 2 |
7 | INTEGRATION OF CLINICAL PHARMACOLOGY | authKW | 359241 | 1% | 100% | 2 |
8 | EXPLORATORY STAGE | authKW | 239493 | 1% | 67% | 2 |
9 | NITAZOXANIDE NTZ | authKW | 239493 | 1% | 67% | 2 |
10 | ADEN PARASITOL | address | 179621 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 527 | 34% | 0% | 57 |
2 | Chemistry, Medicinal | 297 | 13% | 0% | 22 |
3 | Tropical Medicine | 247 | 6% | 0% | 10 |
4 | Microbiology | 214 | 16% | 0% | 27 |
5 | Virology | 152 | 8% | 0% | 13 |
6 | Infectious Diseases | 127 | 9% | 0% | 15 |
7 | Gastroenterology & Hepatology | 105 | 8% | 0% | 14 |
8 | Chemistry, Analytical | 69 | 10% | 0% | 17 |
9 | Parasitiology | 67 | 4% | 0% | 7 |
10 | Biochemical Research Methods | 58 | 7% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATOL GASTROENTEROL INFECT DIS | 431082 | 4% | 40% | 6 |
2 | ADEN PARASITOL | 179621 | 1% | 100% | 1 |
3 | BACTERIOL MOL GENET | 179621 | 1% | 100% | 1 |
4 | BEHA MED | 179621 | 1% | 100% | 1 |
5 | HEPATOL GASTROENTEROL INFECT | 179621 | 1% | 100% | 1 |
6 | HOSP GEN ZONA MED FAMILIAR UNO | 179621 | 1% | 100% | 1 |
7 | KASR EL AINY | 179621 | 1% | 100% | 1 |
8 | LAGEAMB | 179621 | 1% | 100% | 1 |
9 | NACL REFERENCIA SIDA MICROBIOL | 179621 | 1% | 100% | 1 |
10 | ROMARK MED | 179621 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1698 | 9% | 0% | 15 |
2 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1653 | 4% | 0% | 6 |
3 | ANTIVIRAL RESEARCH | 1290 | 3% | 0% | 5 |
4 | TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 937 | 4% | 0% | 6 |
5 | FUTURE MICROBIOLOGY | 717 | 1% | 0% | 2 |
6 | JOURNAL OF INFECTION AND PUBLIC HEALTH | 566 | 1% | 0% | 1 |
7 | CURRENT COMPUTER-AIDED DRUG DESIGN | 525 | 1% | 0% | 1 |
8 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 442 | 2% | 0% | 4 |
9 | CURRENT PHARMACEUTICAL ANALYSIS | 405 | 1% | 0% | 1 |
10 | JOURNAL OF CHROMATOGRAPHIC SCIENCE | 388 | 2% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NITAZOXANIDE | 5705923 | 38% | 49% | 65 | Search NITAZOXANIDE | Search NITAZOXANIDE |
2 | TIZOXANIDE | 1811172 | 6% | 92% | 11 | Search TIZOXANIDE | Search TIZOXANIDE |
3 | THIAZOLIDES | 374204 | 3% | 42% | 5 | Search THIAZOLIDES | Search THIAZOLIDES |
4 | CONFIRMATORY STAGE | 359241 | 1% | 100% | 2 | Search CONFIRMATORY+STAGE | Search CONFIRMATORY+STAGE |
5 | CRYPTONAZ POWDER | 359241 | 1% | 100% | 2 | Search CRYPTONAZ+POWDER | Search CRYPTONAZ+POWDER |
6 | INTEGRATION OF CLINICAL PHARMACOLOGY | 359241 | 1% | 100% | 2 | Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY | Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY |
7 | EXPLORATORY STAGE | 239493 | 1% | 67% | 2 | Search EXPLORATORY+STAGE | Search EXPLORATORY+STAGE |
8 | NITAZOXANIDE NTZ | 239493 | 1% | 67% | 2 | Search NITAZOXANIDE+NTZ | Search NITAZOXANIDE+NTZ |
9 | ALBENDAZOLE ALB | 179621 | 1% | 100% | 1 | Search ALBENDAZOLE+ALB | Search ALBENDAZOLE+ALB |
10 | ARGEMONE MEXICAN | 179621 | 1% | 100% | 1 | Search ARGEMONE+MEXICAN | Search ARGEMONE+MEXICAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ROSSIGNOL, JF , (2014) NITAZOXANIDE: A FIRST-IN-CLASS BROAD-SPECTRUM ANTIVIRAL AGENT.ANTIVIRAL RESEARCH. VOL. 110. ISSUE . P. 94 -103 | 32 | 65% | 30 |
2 | HEGAZY, M , KESSIBA, A , EL GINDY, AE , ABDELKAWY, M , (2014) VALIDATED STABILITY INDICATING RP-HPLC FOR QUANTITATION OF NITAZOXANIDE IN PRESENCE OF ITS ALKALINE DEGRADATION PRODUCTS AND THEIR CHARACTERIZATION BY HPLC-TANDEM MASS SPECTROMETRY.JOURNAL OF CHROMATOGRAPHIC SCIENCE. VOL. 52. ISSUE 9. P. 1071 -1081 | 20 | 87% | 2 |
3 | FOX, LM , SARAVOLATZ, LD , (2005) NITAZOXANIDE: A NEW THIAZOLIDE ANTIPARASITIC AGENT.CLINICAL INFECTIOUS DISEASES. VOL. 40. ISSUE 8. P. 1173-1180 | 24 | 67% | 134 |
4 | ANDERSON, VR , CURRAN, MP , (2007) NITAZOXANIDE - A REVIEW OF ITS USE IN THE TREATMENT OF GASTROINTESTINAL INFECTIONS.DRUGS. VOL. 67. ISSUE 13. P. 1947-1967 | 31 | 48% | 71 |
5 | LIU, XW , ZHANG, H , YANG, YJ , LI, JY , LI, B , ZHOU, XZ , ZHANG, JY , (2014) SYNTHESIS, ANTIBACTERIAL EVALUATION AND MOLECULAR DOCKING STUDY OF NITAZOXANIDE ANALOGUES.ASIAN JOURNAL OF CHEMISTRY. VOL. 26. ISSUE 10. P. 2921-2926 | 17 | 81% | 1 |
6 | ASLAM, S , MUSHER, DM , (2007) NITAZOXANIDE: CLINICAL STUDIES OF A BROAD-SPECTRUM ANTI-INFECTIVE AGENT.FUTURE MICROBIOLOGY. VOL. 2. ISSUE 6. P. 583 -590 | 21 | 75% | 11 |
7 | HEMPHILL, A , MUELLER, J , ESPOSITO, M , (2006) NITAZOXANIDE, A BROAD-SPECTRUM THIAZOLIDE ANTI-INFECTIVE AGENT FOR THE TREATMENT OF GASTROINTESTINAL INFECTIONS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 7. ISSUE 7. P. 953-964 | 27 | 54% | 57 |
8 | ROSSIGNOL, JF , KEEFFE, EB , (2008) THIAZOLIDES: A NEW CLASS OF DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS B AND C.FUTURE MICROBIOLOGY. VOL. 3. ISSUE 5. P. 539-545 | 18 | 82% | 15 |
9 | SALEH, OA , EL-AZZOUNY, AA , ABOUL-ENEIN, HY , BADAWEY, AM , (2014) A VALIDATED HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC (HPLC) ASSAY FOR NITAZOXANIDE IN BULK AND IN PHARMACEUTICAL FORMULATIONS.CURRENT PHARMACEUTICAL ANALYSIS. VOL. 10. ISSUE 3. P. 215 -222 | 14 | 88% | 1 |
10 | ROSSIGNOL, JF , (2009) THIAZOLIDES: A NEW CLASS OF ANTIVIRAL DRUGS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 6. P. 667-674 | 22 | 61% | 13 |
Classes with closest relation at Level 1 |